| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163541 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 06/25/2009 | US20090163531 Use of Tiotropium Salts in the Treatment of Severe Persistent Asthma |
| 06/25/2009 | US20090163518 Novel Compounds |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163482 Tetralines antagonists of the h-3 receptor |
| 06/25/2009 | US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 06/25/2009 | US20090163456 Carbonate and carbamate modified forms of glucocorticoids in combination with b2 adrenergic agonists |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162320 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
| 06/25/2009 | DE102007062411A1 Arzneimittel zur Behandlung von fibrosierenden Lungenkrankheiten Medicines to treat fibrotic lung diseases |
| 06/25/2009 | DE102007061766A1 New 4-(4-cyano-2-thioaryl)-dihydro-pyrimidinone compounds are human neutrophil elastase inhibitor, useful for the treatment or prevention of e.g. pulmonary arterial hypertonia, acute lung injury and diseases of the cardiovascular system |
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | CA2707422A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072051A1 Combination of azelastine and mometasone |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1874781B1 Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 06/24/2009 | EP1641485A4 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1314436B1 Antiviral composition comprising interferon in the form of nose drops |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503566C Inhibitors of cytosolic phospholipase A2 |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502898C Honeysuckle extract, preparation and use thereof |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502882C Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation |
| 06/24/2009 | CN100502872C Effervescence tablet of sulfogaiacol pentoxyverine and its preparation technique |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/24/2009 | CN100502840C Medication for treating chronic rhinitis and nasal sinusitis |
| 06/23/2009 | US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2304820C Stabilized bioactive preparations and methods of use |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009074829A1 Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors |
| 06/18/2009 | WO2009074575A2 Organic compounds |
| 06/18/2009 | WO2009074519A1 Combinations of pyrazolyl or isoxazolyl p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074518A1 Combinations of prolinamide p2x7 modulators with further therapeutic agents |
| 06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | WO2009053748A3 Novel crystalline forms |
| 06/18/2009 | WO2009046864A3 Use of the human pancreatic polypeptide as a therapeutic agent |
| 06/18/2009 | WO2009046847A3 Use of peptide ll-37 as a therapeutic agent |
| 06/18/2009 | WO2009046846A3 Use of il-1 receptor peptide, alone or in combination with peptide ll-37, as a therapeutic agent |
| 06/18/2009 | WO2009043476A3 Neuromedin s as a therapeutic agent |
| 06/18/2009 | WO2009043448A3 Neuromedin u-25 and neuromedin s as therapeutic agents |
| 06/18/2009 | WO2009043440A3 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/18/2009 | WO2009018280A3 Substituted indoles |
| 06/18/2009 | US20090156803 Condensed furan compounds |
| 06/18/2009 | US20090156667 Method of treating asthma, allergic rhinitis, and skin disorders |
| 06/18/2009 | US20090156653 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction |
| 06/18/2009 | US20090156650 Composition that comprises at least one oxime and its use in therapeutics |
| 06/18/2009 | US20090156640 Nociceptin analogs |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 06/18/2009 | US20090156600 Quinolines and Their Therapeutic Use |
| 06/18/2009 | US20090156597 Novel Compounds |
| 06/18/2009 | US20090156575 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/18/2009 | US20090156537 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 06/18/2009 | US20090156513 freeze-dried fruit pulp powder; antioxidants comprises a high concentration of anthocyanin; treating disease or injury and damage induced by pathological free radicals; has a cyclooxygenase inhibition value greater than Aspirin; anticarcinogenic, antiinflammatory, antiarthritic agents; aging resistance |
| 06/18/2009 | US20090155398 Jucara and acai fruit-based dietary supplements |
| 06/18/2009 | US20090155372 Method of manufacturing modified release dosage forms |
| 06/18/2009 | US20090155350 Chlamydia antigens and protein vaccine |
| 06/18/2009 | US20090155302 Antigen Arrays for Treatment of Allergic Eosinophilic Diseases |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |
| 06/18/2009 | US20090155205 HUMAN ANTIBODIES THAT BIND HUMAN TNFa |
| 06/18/2009 | US20090155189 Preparations, Methods and Kits Useful for the Treatment of Cough |
| 06/18/2009 | US20090155186 Compositions and methods for treating inflammatory conditions |
| 06/18/2009 | US20090155185 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 06/18/2009 | CA2709314A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2709288A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | CA2707857A1 Organic compounds |
| 06/18/2009 | CA2706811A1 Novel 2-hetarylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/18/2009 | CA2706679A1 Novel compounds 010 |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070930A1 Polycycloalkylpurines as adenosine receptor antagonists |